Skip to content

Clinical trials

Phase 1/2 Stomach Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 1/2 Country / region: Italy Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20142
20162
20181
20192
20203
20212
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting6
Recruiting4
Completed3
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merus B.V.2
AstraZeneca1
Basilea Pharmaceutica1
BioNTech SE1
Bold Therapeutics, Inc.1
EMD Serono Research & Development Institute, Inc.1
Kymab Limited1
Nektar Therapeutics1
Nouscom SRL1
PharmaMar1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms16
Colorectal Neoplasms9
Carcinoma, Non-Small-Cell Lung6
Pancreatic Neoplasms5
Neoplasms4
Endometrial Neoplasms3
Esophageal Neoplasms3
Melanoma3
Neoplasm Metastasis3
Squamous Cell Carcinoma of Head and Neck3

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.